The role of a single-shot higher-valency pneumococcal vaccine in overcoming challenges regarding invasive pneumococcal disease in Hong Kong
Hong Kong Med J
.
2023 Feb;29(1):11-14.
doi: 10.12809/hkmj235141.
Epub 2023 Feb 8.
Authors
C K M Hui
1
,
I F N Hung
2
3
,
B Lam
4
,
A W C Lin
5
,
T M K So
6
,
A T Y Wong
7
,
M C S Wong
8
9
Affiliations
1
813 Medical Centre, Hong Kong.
2
Queen Mary Hospital, The University of Hong Kong, Hong Kong.
3
Gleneagles Hospital Hong Kong, Hong Kong.
4
Hong Kong Sanatorium & Hospital, Hong Kong.
5
HKSH Medical Group, Hong Kong.
6
Virtus Medical Centre, Hong Kong.
7
Princess Margaret Hospital, Hong Kong.
8
The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
9
Editor-in-Chief, Hong Kong Medical Journal.
PMID:
36751099
DOI:
10.12809/hkmj235141
No abstract available
Keywords:
Hong Kong; Pneumococcal infections; Vaccines, conjugate.
Publication types
Editorial
MeSH terms
Hong Kong
Humans
Infant
Pneumococcal Infections* / prevention & control
Pneumococcal Vaccines*
Streptococcus pneumoniae
Substances
Pneumococcal Vaccines